Novartis Denies Cover-Up Of $1.2M Deal With Michael Cohen
Novartis on Friday disputed a report from Democratic senators that concluded the Swiss drugmaker misled the public about its $1.2 million contract with a former attorney for President Donald Trump.
“We disagree with the report’s conclusion that we issued a misleading public statement regarding the extent of our engagement with (Michael) Cohen,” Novartis said of the report compiled by staff of Sen. Ron Wyden, from Oregon, and other minority party lawmakers.
The report concluded the company’s relationship with Cohen was longer and more detailed than it had previously disclosed.
Among other things, the document contends that former Novartis Chief Executive Joe Jimenez had “multiple additional communications” with Cohen including e-mails and phone calls.
Novartis has previously said it hired Cohen as a consultant on health care policy and that it continued to pay him for a year despite concluding that his advice would be worthless because the agreement could only be terminated for cause.
In its statement on Friday, Novartis reiterated that its deal with Cohen was a mistake, but denied that it sought to conceal a deeper relationship.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO